Difluprednate

• CAT Number: A000854
• CAS Number: 23674-86-4
• Molecular Formula: C27H34F2O7
• Molecular Weight: 508.55
• Purity: ≥95%
• Synonyms: 23674-86-4; Durezol; DFBA; UNII-S8A06QG2QE; Difluoroprednisolone butyrate acetate
• Target: Phospholipase
• Storage: RT
• InChI: InChI=1S/C27H34F2O7/c1-5-6-23(34)36-26(22(33)14-35-15(2)30)10-8-17-18-12-20(28)19-11-16(31)7-9-24(19,3)27(18,29)21(32)13-25(17,26)4/h7,9,11,17-18,20-21,32H,5-6,8,10,12-14H2,1-4H3/t17-,18-,20-,21-,24-,25-,26-,27-/m0/s1
• InChIKey: WYQPLTPSGFELIB-JTQPXKBDSA-N
• SMILES: CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C

Difluprednate is a corticosteroid, It is chemically a butyrate ester of 6(alpha),9(alpha)-difluoro prednisolone acetate. Accordingly, difluprednate is sometimes abbreviated DFBA, for difluoroprednisolone butyrate acetate.

Reference

1: Verhoeven RS, Garcia A, Robeson R, Gilger BC, Culp D, Struble C, Hamm L,
Navratil T, Yerxa B. Nonclinical Development of ENV905 (Difluprednate) Ophthalmic
Implant for the Treatment of Inflammation and Pain Associated with Ocular
Surgery. J Ocul Pharmacol Ther. 2017 Jun 26. doi: 10.1089/jop.2016.0195. [Epub
ahead of print] PubMed PMID: 28650720.

2: Abessi B, Brooksby L, Schultze RL. Comparison of Efficacy of Difluprednate
0.05% and Loteprednol Gel 0.5% After Cataract Surgery. Eye Contact Lens. 2017 Jun
16. doi: 10.1097/ICL.0000000000000407. [Epub ahead of print] PubMed PMID:
28628490.

3: Tijunelis MA, Person E, Niziol LM, Musch DC, Ernest P, McBain M, Mian SI.
Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion
0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular
hypertension. J Cataract Refract Surg. 2017 Feb;43(2):223-227. doi:
10.1016/j.jcrs.2017.02.002. PubMed PMID: 28366370.

4: Mercado-Sesma A, Contreras-Rubio A, Baiza-Durán L, Olvera-Montaño O,
Miranda-Robles M, Bonilla-García J. Bioavailability of generic 0.05%
difluprednate emulsion in the aqueous humor, cornea, and conjunctiva of New
Zealand rabbits after a single dose compared with commercial difluprednate. J
Ophthalmic Inflamm Infect. 2017 Dec;7(1):10. doi: 10.1186/s12348-017-0127-2. Epub
2017 Mar 21. PubMed PMID: 28324274; PubMed Central PMCID: PMC5360744.

5: Garg P, Tuteja N, Qayum S. To Study the Efficacy of Difluprednate Ophthalmic
Emulsion and Prednisolone Acetate Ophthalmic Suspension on Post-operative
Inflammation in Cataract Surgery. J Clin Diagn Res. 2016 Dec;10(12):NC05-NC08.
doi: 10.7860/JCDR/2016/21690.9035. Epub 2016 Dec 1. PubMed PMID: 28208898; PubMed
Central PMCID: PMC5296471.

6: Kusne Y, Kang P, Fintelmann RE. A retrospective analysis of intraocular
pressure changes after cataract surgery with the use of prednisolone acetate 1%
versus difluprednate 0.05%. Clin Ophthalmol. 2016 Nov 23;10:2329-2336.
eCollection 2016. PubMed PMID: 27920493; PubMed Central PMCID: PMC5125796.

7: Kaur S, Sukhija J. Difluprednate versus prednisolone acetate for inflammation
following cataract surgery in pediatric patients: a randomized safety and
efficacy study. Eye (Lond). 2017 Mar;31(3):506. doi: 10.1038/eye.2016.243. Epub
2016 Nov 4. PubMed PMID: 27813525; PubMed Central PMCID: PMC5350369.

8: Wilson ME, Lambert SR, Plager DA, VanderVeen D, Roarty J, O/’Halloran H.
Difluprednate versus prednisolone acetate for inflammation following cataract
surgery in pediatric patients: a randomized safety and efficacy study. Eye
(Lond). 2017 Mar;31(3):506-507. doi: 10.1038/eye.2016.244. Epub 2016 Nov 4.
PubMed PMID: 27813524; PubMed Central PMCID: PMC5350370.

9: Lu S, Taban M. Topical difluprednate for treatment of serous retinal
detachment and panuveitis associated with Vogt-Koyanagi-Harada disease. Digit J
Ophthalmol. 2016 Jun 28;22(2):54-7. doi: 10.5693/djo.02.2015.05.004. eCollection
2016. PubMed PMID: 27582676; PubMed Central PMCID: PMC4990084.

10: Feiler DL, Srivastava SK, Pichi F, Bena J, Lowder CY. RESOLUTION OF
NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE. Retina.
2017 May;37(5):844-850. doi: 10.1097/IAE.0000000000001243. PubMed PMID: 27529841.